Stock Taper 
EXOME ASSET MANAGEMENT LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Verastem, Inc. | VSTM | 429.04K | $1.64M |
 Cogent Biosciences, Inc. | COGT | 210.52K | $8.15M |
 Alumis Inc. | ALMS | 204.42K | $5.75M |
 Ocular Therapeutix, Inc. | OCUL | 181.59K | $1.78M |
 MoonLake Immunotherapeutics | MLTX | 166.49K | $3.24M |
 TG Therapeutics, Inc. | TGTX | 164.91K | $9.06M |
 Monte Rosa Therapeutics, Inc. | GLUE | 137.12K | $3.32M |
 10x Genomics, Inc. | TXG | 102.63K | $3.93M |
 Enliven Therapeutics, Inc. | ELVN | 100.2K | $5.09M |
 Vera Therapeutics, Inc. | VERA | 97.28K | $4.17M |
 Ionis Pharmaceuticals, Inc. | IONS | 88.18K | $6.99M |
 ClearPoint Neuro, Inc. | CLPT | 83.64K | $1.49M |
 uniQure N.V. | QURE | 81.06K | $3.73M |
 Caris Life Sciences, Inc. | CAI | 78.18K | $1.39M |
 Agios Pharmaceuticals, Inc. | AGIO | 70.5K | $2.62M |
 Guardant Health, Inc. | GH | 67.5K | $10.13M |
 Alkermes plc | ALKS | 61.34K | $3.21M |
 Cytokinetics, Incorporated | CYTK | 60.06K | $5.12M |
 Zenas BioPharma, Inc. | ZBIO | 52.44K | $1.33M |
 Arbutus Biopharma Corp | ABUS | 50.17K | $240.8K |